WASHINGTON, July 2 -- Rep. John Moolenaar, R-Michigan, chairman of the House Select Committee on the Strategic Competition Between the U.S. and the Chinese Communist Party, issued the following news release on June 30, 2026:

* * *

Select Committee Investigates Bristol Myers Squibb For Clinical Trials at Chinese Military Sites

Chairman John Moolenaar of the Select Committee on China has sent a letter to Bristol Myers Squibb Chief Executive Officer Chris Boer . . .

Click here for more information about our products